ICTI Acquires Leading EDC Software

March 9, 2005

On 9th March, Interactive Clinical Technologies, Inc. (ICTI), a global leader in interactive clinical trial management solutions acquired leading EDC software, MetaTrial 4.0, along with all EDC related staff from ViPS Biomedical Services Inc.  This acquisition expands ICTI’s offerings to include electronic data capture (EDC) software and services.  The marriage of ICTI’s interactive voice response (IVR) capabilities with EDC will provide trial sponsors with opportunities to further accelerate clinical trials, increase data quality, and reduce costs.

Richard McCann, President of ICTI, commented, “As we looked at opportunities to offer greater value to our clients, EDC was a logical step.  We examined several EDC options, and, based on our thorough review, we believe that MetaTrial 4.0 software is a truly superior EDC product.  Furthermore, our discussions with clients indicated that they are very impressed with the software and also with the quality of the support they have received from the EDC team, particularly in comparison with other leading EDC vendors.”

Karen Borda, who will take the position of Vice President of New Products and Services at ICTI with responsibility for EDC Services added, “Our team is delighted with this development.  The combination of our EDC technology and experience with ICTI’s IVR technology and experience will enable us to offer the industry leading integrated IVR and EDC solution.”

MetaTrial 4.0 software has the capability to work both on-line and off-line, providing the opportunity to conduct clinical research in any environment.  In addition, the EDC team joining ICTI have experience with a wide variety of clinical trial sponsors including major pharmaceutical companies, leading CROs, academic researchers, biotechnology companies and medical device manufacturers.

About ICTI and Almac Sciences

ICTI is a division of Almac Sciences specializing in the implementation of interactive clinical trial management solutions. ICTI’s clinical technology and services enable clients to accelerate the clinical trial process, increase data quality, and reduce costs.  Services include Interactive Voice Response Systems (IVRS), Electronic Data Capture (EDC), Clinical Supplies Management and Forecasting, Electronic Patient Reported Outcomes (ePRO), Clinical Hotline, Biostatistical Services, and Patient Recruitment Systems.

Almac Sciences and its affiliated companies: CSS (Chemical Synthesis Services); CTS (Clinical Trial Services); ICTI (Interactive Clinical Technologies Incorporated); PDMS (Pharmaceutical Development & Manufacturing Services) and ArraDx (Array Based Diagnostics) provide a broad range of pharmaceutical services across drug discovery, diagnostics, research and development, manufacture of API, clinical trials and drug product manufacture. US operations are based in Pennsylvania, North Carolina and California.  European operations are based out of corporate headquarters in Craigavon, Northern Ireland with additional operations in London and Edinburgh.

Contact information:

Jim Murphy, VP Business Development or

Anne Zielinski, Director Business Development

i[email protected] or US: (267) 685-4284



Back to news